Last patient has completed AlzeCure's Phase Ib clinical study with NeuroRestore ACD856
AlzeCure Pharma AB (publ), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer’s disease and pain, today announced that the last patient’s last…